Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Canopy Growth's annualizedNet Income for the quarter that ended in Jun. 2023 was $-114.8 Mil. Canopy Growth's average total tangible assets for the quarter that ended in Jun. 2023 was $1,514.8 Mil. Therefore, Canopy Growth's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2023 was -7.58%.
The historical rank and industry rank for Canopy Growth's Return-on-Tangible-Asset or its related term are showing as below:
CGC'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -116.02 Med: -15.95 Max: -3.86
Current: -47.68
During the past 13 years, Canopy Growth's highest Return-on-Tangible-Asset was -3.86%. The lowest was -116.02%. And the median was -15.95%.
CGC's Return-on-Tangible-Asset is ranked worse than 80.73% of 1121
companies
in the Drug Manufacturers industry
Industry Median: 1.82
vs CGC: -47.68
Canopy Growth Return-on-Tangible-Asset Historical Data
The historical data trend for Canopy Growth's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Canopy Growth Annual Data
Trend
Jul13
Dec14
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
Mar23
Return-on-Tangible-Asset
-19.45
-23.53
-40.52
-7.61
-110.51
Canopy Growth Quarterly Data
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Return-on-Tangible-Asset
-250.54
-28.12
-36.31
-117.42
-7.58
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Canopy Growth Return-on-Tangible-Asset Distribution
For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Canopy Growth's Return-on-Tangible-Asset falls in comparison to its industry or sector. The grey bar indicates the Return-on-Tangible-Asset's extreme value range as defined by GuruFocus.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2023) net income data.
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Canopy Growth Return-on-Tangible-Asset Related Terms
Thank you for viewing the detailed overview of Canopy Growth's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include sports drink BioSteel, skincare products under This Works, Martha Stewart CBD, and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
0.07(9.48%) Volume: 71,992,310 11:09PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
CGC has been successfully added to your 
